20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Valsartan Intermediate: Ensuring Quality with 5-(4'-Bromomethylbiphenyl-2-yl)-1-triphenylmethyltetrazole

Valsartan, a highly effective medication for treating high blood pressure and heart failure, is a cornerstone of cardiovascular pharmacotherapy. The efficient and high-quality synthesis of Valsartan relies heavily on key intermediates, with 5-(4'-Bromomethylbiphenyl-2-yl)-1-triphenylmethyltetrazole (CAS 124750-51-2) playing a crucial role.

NINGBO INNO PHARMCHEM CO.,LTD. serves the pharmaceutical industry as a leading manufacturer and supplier of essential chemical intermediates. We provide CAS 124750-51-2, a vital building block for the synthesis of Valsartan. Our commitment to excellence ensures that manufacturers can rely on our product for consistent quality and performance.

The intricate structure of 5-(4'-Bromomethylbiphenyl-2-yl)-1-triphenylmethyltetrazole is designed to integrate seamlessly into the multi-step synthesis of Valsartan. The biphenyl-tetrazole moiety is characteristic of the Angiotensin II Receptor Blocker (ARB) class, and the bromomethyl group provides a reactive handle for further chemical modification. When you choose to buy this intermediate from us, you are opting for a product that is manufactured to stringent purity standards (≥97%), minimizing the risk of unwanted byproducts in your API.

For pharmaceutical companies manufacturing Valsartan, the selection of an intermediate supplier is a critical decision impacting both product quality and production efficiency. A reliable manufacturer ensures consistent availability, reducing the risk of supply chain disruptions. We understand this need and are dedicated to providing a dependable source for this essential intermediate.

Furthermore, competitive price is a significant consideration for procurement professionals. We aim to deliver exceptional value by offering high-quality 5-(4'-Bromomethylbiphenyl-2-yl)-1-triphenylmethyltetrazole at competitive rates, supporting the cost-effectiveness of your Valsartan production. Partnering with NINGBO INNO PHARMCHEM CO.,LTD. means securing a critical intermediate from a trusted manufacturer, ensuring the quality and integrity of your final pharmaceutical product.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Critical Link: 124750-51-2 in Olmesartan Medoxomil Synthesis

Next: Manufacturer Focus: Quality Sourcing of Pharmaceutical Intermediates

All Rights Reserved